- Report
- March 2022
- 40 Pages
France
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2022
- 40 Pages
China
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2022
- 40 Pages
Brazil
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
India
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Japan
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
United Kingdom
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
United States
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Global
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
North America
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Asia Pacific
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Europe
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
China
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
France
From €907EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Germany
From €907EUR$950USD£760GBP
- Report
- January 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- November 2021
- 1032 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Book
- March 2010
- 784 Pages
- Book
- May 2022
- 512 Pages

Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, such as cancer. Cancer markers are a type of biomarker that can be used to detect the presence of cancer in a patient. They can be used to diagnose, monitor, and predict the progression of cancer. Cancer markers can be proteins, hormones, enzymes, or other molecules that are produced by cancer cells or are associated with the presence of cancer.
Cancer markers are used in a variety of ways, including to detect the presence of cancer, to monitor the progression of the disease, and to predict the response to treatment. They can also be used to identify patients who are at risk for developing cancer.
The cancer marker market is a rapidly growing segment of the biomarker market. It is driven by the increasing prevalence of cancer, the development of new technologies for detecting and monitoring cancer, and the increasing demand for personalized medicine.
Companies in the cancer marker market include Abbott Laboratories, Agilent Technologies, Becton Dickinson, Bio-Rad Laboratories, Cepheid, and Roche Diagnostics. Show Less Read more